Statistical analysis was based on the method of intent-to-treat and determined that IFN-α treatment improved the overall survival of patients with HBV-associated HCC following curative resection, possibly by postponing recurrence. This evidence concerns the gene IFNA1 and hepatocellular carcinoma.